Free Trial

JMP Securities Issues Positive Forecast for Bowhead Specialty (NYSE:BOW) Stock Price

Bowhead Specialty logo with Finance background

Bowhead Specialty (NYSE:BOW - Get Free Report) had its price objective hoisted by stock analysts at JMP Securities from $38.00 to $40.00 in a research report issued on Friday,Benzinga reports. The firm presently has a "market outperform" rating on the stock. JMP Securities' price objective would suggest a potential upside of 0.60% from the company's current price.

BOW has been the subject of several other reports. Keefe, Bruyette & Woods reduced their price target on Bowhead Specialty from $44.00 to $43.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. JPMorgan Chase & Co. raised their price objective on shares of Bowhead Specialty from $30.00 to $35.00 and gave the company a "neutral" rating in a research note on Tuesday, April 8th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, Bowhead Specialty has a consensus rating of "Moderate Buy" and an average price target of $37.17.

View Our Latest Analysis on Bowhead Specialty

Bowhead Specialty Trading Up 0.5 %

Shares of NYSE BOW traded up $0.20 during mid-day trading on Friday, hitting $39.76. 148,043 shares of the stock traded hands, compared to its average volume of 211,990. The stock has a fifty day moving average price of $36.01 and a 200-day moving average price of $33.90. Bowhead Specialty has a 52 week low of $22.14 and a 52 week high of $42.29.

Bowhead Specialty (NYSE:BOW - Get Free Report) last announced its earnings results on Tuesday, February 25th. The company reported $0.42 earnings per share for the quarter, beating analysts' consensus estimates of $0.35 by $0.07. The business had revenue of $184.77 million for the quarter, compared to the consensus estimate of $102.12 million. Research analysts forecast that Bowhead Specialty will post 1.36 earnings per share for the current fiscal year.

Insider Buying and Selling at Bowhead Specialty

In related news, Director Ava Schnidman acquired 1,493 shares of the firm's stock in a transaction dated Friday, February 28th. The stock was purchased at an average cost of $33.41 per share, with a total value of $49,881.13. Following the completion of the acquisition, the director now directly owns 1,893 shares of the company's stock, valued at approximately $63,245.13. This trade represents a 373.25 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Institutional Investors Weigh In On Bowhead Specialty

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Summit Investment Advisors Inc. boosted its stake in shares of Bowhead Specialty by 66.4% in the 4th quarter. Summit Investment Advisors Inc. now owns 1,218 shares of the company's stock worth $43,000 after buying an additional 486 shares during the last quarter. New York State Common Retirement Fund purchased a new position in Bowhead Specialty in the fourth quarter worth about $64,000. US Bancorp DE bought a new stake in shares of Bowhead Specialty during the 4th quarter valued at about $76,000. KLP Kapitalforvaltning AS purchased a new stake in shares of Bowhead Specialty during the 4th quarter valued at about $107,000. Finally, GAMMA Investing LLC boosted its holdings in shares of Bowhead Specialty by 7,651.2% in the first quarter. GAMMA Investing LLC now owns 3,333 shares of the company's stock worth $135,000 after buying an additional 3,290 shares during the last quarter.

Bowhead Specialty Company Profile

(Get Free Report)

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.

Further Reading

Analyst Recommendations for Bowhead Specialty (NYSE:BOW)

Should You Invest $1,000 in Bowhead Specialty Right Now?

Before you consider Bowhead Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.

While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines